A New Approach to Migraines from Amgen
Recombinetics is Improving Animal Welfare Using Biotechnology
Janssen Pharmaceuticals’ New Model Will Put Patients First
First Approved Treatment using RNAi – Alnylam Pharmaceuticals’ and BIO Chair John Maraganore
Curing the Worlds Most Debilitating Diseases -- Dr. Penny Heaton, Gates MRI CEO
Monday Highlights: BIO 2018
By Connor McKoy, July 19, 2018
Following Food, Health and Environmental Future Day at the 2018 BIO International Convention, BIO’s Executive ...